Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.72 USD | +1.48% | -2.67% | +31.94% |
09/05 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
08/05 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.94% | 6.13B | |
+27.43% | 48.16B | |
-1.00% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.14% | 25.59B | |
-22.97% | 18.96B | |
+7.90% | 12.92B | |
+29.11% | 12.03B | |
-2.22% | 11.77B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Needham Adjusts Revolution Medicines Price Target to $36 From $34, Maintains Buy Rating